ArticleAging2023

The cell senescence regulator p16 is a promising cancer prognostic and immune check-point inhibitor (ICI) therapy biomarker.

Zewei Tu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.